CCR7 and lymphoma: In POD24‐FLs, weak CXCR3 and CXCR4 expression was found in 13.33% and 40% of lymphoma cells, with moderate CCR3 and CXCR5, and strong CCR7 in 50%, 70%, and 50%, respectively (Figure 5b; Table 2).